CIK: 1783165 - Address: C/O Adjuvant Capital, L.P., 501 Fifth Avenue, Suite 1404, New York, NY 10017
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/18/24 18:18
1/16/24
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS-1,96519.650-100-42,374M
11/16/23 18:59
11/14/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS-2916.150-202,474M
10/3/23 19:13
9/29/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS.m-1,70516.270-105-42,475M
9/29/23 17:41
9/27/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS.m-15116.110-902,580M
9/15/23 17:17
9/13/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS-616.000002,589M
9/8/23 16:59
9/6/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS.m-11416.030-702,590M
8/25/23 16:31
8/23/23
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTS-616.000002,597M
6/24/22 16:51
3/29/22
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTP.ad2,50015.00016772,597M
3/31/22 20:15
3/29/22
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTP.d2,50015.00016772,597I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact